Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Informa UK Limited - Tập Volume 13 - Trang 757-777
Marco Solmi1,2, Andréa Murru3,4,5, Isabella Pacchiarotti3,4,5, Juan Undurraga6,7, Nicola Veronese8,2, Michele Fornaro9,10, Brendon Stubbs11,12,2, Francesco Monaco2, Eduard Vieta3,4,5,13, Mary V. Seeman, Christoph U. Correll14,15, André F. Carvalho16,17,2
1Neuroscience Department, University of Padua,
2Institute for Clinical Research and Education in Medicine, Padua, Italy
3Bipolar Disorders Unit, institute of Neuroscience,
4Hospital Clínic, University of Barcelona,
5iDiBAPS, CiBeRSAM, Barcelona, Catalonia, Spain;
6Department of Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo,
7Early Intervention Program, J. Horwitz Psychiatric Institute, Santiago, Chile
8National Research Council, Ageing Section, Padua,
9Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, School of Medicine, University "Federico ii", Naples, italy;
10New York State Psychiatric Institute, Columbia University, New York, NY, USA
11Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, UK
12Health Service and Population Research Department, institute of Psychiatry, Psychology and Neuroscience, King's College London,
13Institute of Medical Science, Toronto, ON, Canada
14Department of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks,
15Department of Psychiatry and Molecular Medicine Hempstead, Hofstra Northwell School of Medicine, Hempstead, NY, USA;
16Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
17Translational Psychiatry Research Group and Department of Clinical Medicine,
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Informa UK Limited
Tập Volume 13
757-777
Thông tin tác giả